Open Access
Open access
Journal of Medicinal Chemistry, volume 61, issue 3, pages 1255-1260

In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors

Cain Ricky L 1
Brem Jurgen 2
Zollman David 2
McDonough Michael 2
Johnson Rachel M. 1
Spencer James 3
Makena Anne 2
Abboud Martine I. 2
Cahill Samuel T 2
Lee Sook Y 2, 4
Mchugh Peter J 4
Schofield Christopher J. 2
WG Fishwick Colin 1
1
 
School of Chemistry, University of Leeds, Leeds LS2 9JT, United Kingdom
3
 
School of Cellular and Molecular Medicine, University of Bristol, Biomedical Sciences Building, Bristol BS8 1TD, United Kingdom
Publication typeJournal Article
Publication date2018-01-10
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.3
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Abstract
Zinc ion-dependent β-lactamases (MBLs) catalyze the hydrolysis of almost all β-lactam antibiotics and resist the action of clinically available β-lactamase inhibitors. We report how application of in silico fragment-based molecular design employing thiol-mediated metal anchorage leads to potent MBL inhibitors. The new inhibitors manifest potent inhibition of clinically important B1 subfamily MBLs, including the widespread NDM-1, IMP-1, and VIM-2 enzymes; with lower potency, some of them also inhibit clinically relevant Class A and D serine-β-lactamases. The inhibitors show selectivity for bacterial MBL enzymes compared to that for human MBL fold nucleases. Cocrystallization of one inhibitor, which shows potentiation of Meropenem activity against MBL-expressing Enterobacteriaceae, with VIM-2 reveals an unexpected binding mode, involving interactions with residues from conserved active site bordering loops.

Citations by journals

1
2
3
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 3, 8.11%
European Journal of Medicinal Chemistry
3 publications, 8.11%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 2, 5.41%
Journal of Medicinal Chemistry
2 publications, 5.41%
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 2, 5.41%
Journal of Global Antimicrobial Resistance
2 publications, 5.41%
ChemMedChem
ChemMedChem, 2, 5.41%
ChemMedChem
2 publications, 5.41%
Chemical Reviews
Chemical Reviews, 2, 5.41%
Chemical Reviews
2 publications, 5.41%
ACS Infectious Diseases
ACS Infectious Diseases, 2, 5.41%
ACS Infectious Diseases
2 publications, 5.41%
Combinatorial Chemistry and High Throughput Screening
Combinatorial Chemistry and High Throughput Screening, 1, 2.7%
Combinatorial Chemistry and High Throughput Screening
1 publication, 2.7%
Antibiotics
Antibiotics, 1, 2.7%
Antibiotics
1 publication, 2.7%
Biomolecules
Biomolecules, 1, 2.7%
Biomolecules
1 publication, 2.7%
ACS Omega
ACS Omega, 1, 2.7%
ACS Omega
1 publication, 2.7%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 2.7%
International Journal of Molecular Sciences
1 publication, 2.7%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 2.7%
Frontiers in Microbiology
1 publication, 2.7%
Medicinal Chemistry Research
Medicinal Chemistry Research, 1, 2.7%
Medicinal Chemistry Research
1 publication, 2.7%
Nature Reviews Chemistry
Nature Reviews Chemistry, 1, 2.7%
Nature Reviews Chemistry
1 publication, 2.7%
Microbiological Research
Microbiological Research, 1, 2.7%
Microbiological Research
1 publication, 2.7%
Journal of Inorganic Biochemistry
Journal of Inorganic Biochemistry, 1, 2.7%
Journal of Inorganic Biochemistry
1 publication, 2.7%
Trends in Pharmacological Sciences
Trends in Pharmacological Sciences, 1, 2.7%
Trends in Pharmacological Sciences
1 publication, 2.7%
Chemical Biology and Drug Design
Chemical Biology and Drug Design, 1, 2.7%
Chemical Biology and Drug Design
1 publication, 2.7%
Medicinal Research Reviews
Medicinal Research Reviews, 1, 2.7%
Medicinal Research Reviews
1 publication, 2.7%
ACS Catalysis
ACS Catalysis, 1, 2.7%
ACS Catalysis
1 publication, 2.7%
MedChemComm
MedChemComm, 1, 2.7%
MedChemComm
1 publication, 2.7%
RSC Medicinal Chemistry
RSC Medicinal Chemistry, 1, 2.7%
RSC Medicinal Chemistry
1 publication, 2.7%
FEMS Microbiology Reviews
FEMS Microbiology Reviews, 1, 2.7%
FEMS Microbiology Reviews
1 publication, 2.7%
Journal of Biomolecular Structure and Dynamics
Journal of Biomolecular Structure and Dynamics, 1, 2.7%
Journal of Biomolecular Structure and Dynamics
1 publication, 2.7%
Science advances
Science advances, 1, 2.7%
Science advances
1 publication, 2.7%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 1, 2.7%
Bioorganic and Medicinal Chemistry
1 publication, 2.7%
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, 1, 2.7%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 2.7%
1
2
3

Citations by publishers

1
2
3
4
5
6
7
8
9
Elsevier
Elsevier, 9, 24.32%
Elsevier
9 publications, 24.32%
American Chemical Society (ACS)
American Chemical Society (ACS), 8, 21.62%
American Chemical Society (ACS)
8 publications, 21.62%
Wiley
Wiley, 4, 10.81%
Wiley
4 publications, 10.81%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 8.11%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 8.11%
Springer Nature
Springer Nature, 2, 5.41%
Springer Nature
2 publications, 5.41%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 5.41%
Royal Society of Chemistry (RSC)
2 publications, 5.41%
Taylor & Francis
Taylor & Francis, 2, 5.41%
Taylor & Francis
2 publications, 5.41%
Bentham Science
Bentham Science, 1, 2.7%
Bentham Science
1 publication, 2.7%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.7%
Frontiers Media S.A.
1 publication, 2.7%
Oxford University Press
Oxford University Press, 1, 2.7%
Oxford University Press
1 publication, 2.7%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 1, 2.7%
American Association for the Advancement of Science (AAAS)
1 publication, 2.7%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Cain R. L. et al. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 3. pp. 1255-1260.
GOST all authors (up to 50) Copy
Cain R. L., Brem J., Zollman D., McDonough M., Johnson R. M., Spencer J., Makena A., Abboud M. I., Cahill S. T., Lee S. Y., Mchugh P. J., Schofield C. J., WG Fishwick C. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors // Journal of Medicinal Chemistry. 2018. Vol. 61. No. 3. pp. 1255-1260.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.7b01728
UR - https://doi.org/10.1021%2Facs.jmedchem.7b01728
TI - In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
T2 - Journal of Medicinal Chemistry
AU - Zollman, David
AU - Makena, Anne
AU - Lee, Sook Y
AU - Abboud, Martine I.
AU - Schofield, Christopher J.
AU - WG Fishwick, Colin
AU - Cain, Ricky L
AU - Brem, Jurgen
AU - McDonough, Michael
AU - Johnson, Rachel M.
AU - Spencer, James
AU - Cahill, Samuel T
AU - Mchugh, Peter J
PY - 2018
DA - 2018/01/10 00:00:00
PB - American Chemical Society (ACS)
SP - 1255-1260
IS - 3
VL - 61
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex Copy
@article{2018_Cain,
author = {David Zollman and Anne Makena and Sook Y Lee and Martine I. Abboud and Christopher J. Schofield and Colin WG Fishwick and Ricky L Cain and Jurgen Brem and Michael McDonough and Rachel M. Johnson and James Spencer and Samuel T Cahill and Peter J Mchugh},
title = {In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2018},
volume = {61},
publisher = {American Chemical Society (ACS)},
month = {jan},
url = {https://doi.org/10.1021%2Facs.jmedchem.7b01728},
number = {3},
pages = {1255--1260},
doi = {10.1021/acs.jmedchem.7b01728}
}
MLA
Cite this
MLA Copy
Cain, Ricky L., et al. “In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.” Journal of Medicinal Chemistry, vol. 61, no. 3, Jan. 2018, pp. 1255-1260. https://doi.org/10.1021%2Facs.jmedchem.7b01728.
Found error?